NT‐ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non‐ST‐elevation acute coronary syndrome

References

• Sabatine M. S., Morrow D. A., de Lemos J. A., et al. Multimarker approach to risk stratification in non‐ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C‐reactive protein, and B‐type natriuretic peptide. Circulation 2002; 105: 1760–3
   PubMed Web of Science ®Google Scholar
• Omland T., Persson A., Ng L., et al. N‐terminal pro‐B‐type natriuretic peptide and long‐term mortality in acute coronary syndromes. Circulation 2002; 106: 2913–8
   PubMed Web of Science ®Google Scholar
• Jernberg T., Lindahl B., Siegbahn A., et al. N‐terminal pro‐brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 2003; 42: 1909–16
   PubMed Web of Science ®Google Scholar
• Morrow D. A., de Lemos J. A., Sabatine M. S., et al. Evaluation of B‐type natriuretic peptide for risk assessment in unstable angina/non‐ST‐elevation myocardial infarction: B‐type natriuretic peptide and prognosis in TACTICS‐TIMI 18. J Am Coll Cardiol 2003; 41: 1264–72
   PubMed Web of Science ®Google Scholar
• James S. K., Lindahl B., Siegbahn A., et al. N‐terminal Pro‐Brain Natriuretic Peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 2003; 108: 275–81
   PubMed Web of Science ®Google Scholar
• Jernberg T., James S., Lindahl B., Stridsberg M., Venge P., Wallentin L. NT‐proBNP in unstable coronary artery disease – experience from the FAST, GUSTO IV and FRISC II trials. Eur J Heart Fail 2004; 6: 319–25
   PubMed Web of Science ®Google Scholar
• Heeschen C., Hamm C. W., Motrovic V., et al. N‐terminal pro‐B‐type Natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206–12
   PubMed Web of Science ®Google Scholar
• Goetze J. P., Christoffersen M., Perko H., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17: 1105–7
   PubMed Web of Science ®Google Scholar
• Riezebos R. K., Ronner E., de Boer B. A., et al. Dynamics in NT‐proBNP concentration in patients with NSTEACS. Am Heart J 2005; 150: 1255–9
   PubMedGoogle Scholar
• Sabatine M. S., Morrow D. A., de Lemos J. A., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44: 1988–95
   PubMed Web of Science ®Google Scholar
• Sadanandan S., Cannon C. P., Chekuri K., et al. Association of elevated B‐type natriuretic peptide levels with angiographic findings among patients with unstable angina and non‐ST‐segment elevation myocardial infarction. J Am Coll Cardiol 2004; 44: 564–8
   PubMed Web of Science ®Google Scholar
• Yeo K. J., Wu A. H., Apple F. S., et al. Multicentre evaluation of the Roche NT‐proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003; 338: 107–15
   PubMed Web of Science ®Google Scholar
• Hallermayer K., Klenner D., Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Invest 1999; Suppl 230: 128–31
   Google Scholar
• Wurzburg U., Hennrich N., Orth H. D., et al. Quantitative determination of creatine kinase isoenzyme catalytic concentrations in serum using immunological methods. J Clin Chem Clin Biochem 1977; 15: 131
   PubMedGoogle Scholar
• Kiemeneij F., Laarman G. J., Slagboom T., van der Wieken R. Outpatient coronary stent implantation. J Am Coll Cardiol 1997; 29: 323–7
   PubMed Web of Science ®Google Scholar
• Karha J., Murphy S. A., Kirtane A. J., et al. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. Am J Cardiol 2003; 92: 913–8
   PubMedGoogle Scholar
• Talwar S., Squire I. B., Davies J. E. Plasma N‐terminal probrain natriuretic peptide and the ECG in the assessment of left‐ventricular systolic dysfunction in a high risk population. Eur Heart J 1999; 20: 1736–44
   PubMed Web of Science ®Google Scholar
• Ioannidis J. P. A., Karvourni E., Katritis D. G. Mortality risk conferred by small elevations of creatinine kinase‐MB isoenzyme after percutaneous intervention. J Am Coll Cardiol 2003; 42: 1406–11
   PubMed Web of Science ®Google Scholar
• De Winter R. J., Windhausen F., Cornel J. H., et al. Early invasive versus selective invasive managements for acute coronary syndromes. N Engl J Med 2005; 353: 1095–104
   PubMed Web of Science ®Google Scholar